Clinical Trial: Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423273) titled 'Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression' on April 15, 2024.

Brief Summary: The study evaluates the effect of HBOT on depression in patients suffering from persistent symptoms of post stroke depression (PSD) in an double blind sham control study.

Study Start Date: Nov. 08, 2023

Study Type: INTERVENTIONAL

Condition: Post Stroke Depression

Intervention: DEVICE: hyperbaric oxygen therapy

The HBOT protocol consists of 60 daily sessions, five times per week, each session lasting 90 minutes.

Investigational product:

Multiplace hyperbaric oxygen chamber (Haux, Germany) located at the Sagol Center for Hyperba...